A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Cerus Corp stock. As of the latest transaction made, Gotham Asset Management, LLC holds 12,587 shares of CERS stock, worth $20,894. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,587
Previous 12,843 1.99%
Holding current value
$20,894
Previous $22,000 4.55%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.7 - $2.39 $435 - $611
-256 Reduced 1.99%
12,587 $21,000
Q2 2024

Aug 14, 2024

SELL
$1.62 - $2.04 $9,007 - $11,342
-5,560 Reduced 30.21%
12,843 $22,000
Q1 2024

May 15, 2024

BUY
$1.66 - $2.42 $3,240 - $4,723
1,952 Added 11.87%
18,403 $34,000
Q4 2023

Feb 14, 2024

SELL
$1.25 - $2.35 $2,943 - $5,534
-2,355 Reduced 12.52%
16,451 $35,000
Q3 2023

Nov 14, 2023

SELL
$1.5 - $3.07 $1,758 - $3,598
-1,172 Reduced 5.87%
18,806 $30,000
Q2 2023

Aug 14, 2023

SELL
$1.79 - $2.9 $2,876 - $4,660
-1,607 Reduced 7.44%
19,978 $49,000
Q1 2023

May 15, 2023

SELL
$2.65 - $3.81 $10,006 - $14,386
-3,776 Reduced 14.89%
21,585 $64,000
Q4 2022

Feb 14, 2023

SELL
$3.38 - $4.22 $1,365 - $1,704
-404 Reduced 1.57%
25,361 $92,000
Q3 2022

Nov 14, 2022

SELL
$3.43 - $5.83 $26,153 - $44,453
-7,625 Reduced 22.84%
25,765 $93,000
Q2 2022

Aug 15, 2022

BUY
$4.41 - $5.69 $77,060 - $99,427
17,474 Added 109.79%
33,390 $177,000
Q1 2022

May 16, 2022

SELL
$4.81 - $6.99 $269 - $391
-56 Reduced 0.35%
15,916 $87,000
Q4 2021

Feb 14, 2022

BUY
$5.97 - $7.93 $95,352 - $126,657
15,972 New
15,972 $109,000
Q3 2019

Nov 14, 2019

SELL
$4.86 - $6.05 $56,414 - $70,228
-11,608 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$4.51 - $6.6 $52,352 - $76,612
11,608 New
11,608 $65,000
Q3 2018

Nov 14, 2018

SELL
$6.89 - $7.78 $167,130 - $188,719
-24,257 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$5.19 - $7.25 $125,893 - $175,863
24,257 New
24,257 $162,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $294M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.